Update on human ¿<sub>1</sub>-adrenoceptor subtype signaling and genomic organization
Gregory A. Michelotti, Sophie-Pénélope Guénin, Francis Cogé, K. Ashley Hawrylyshyn, Debra A. Schwinn
págs. 449-455
Sex and drug abuse: a role for retrograde endocannabinoids?
Mauro Maccarrone
págs. 455-456
Pharmacogenomics in cancer therapy: is host genome variability important?
William P. Petros, William E. Evans
págs. 457-464
Targeting Ca<sup>2+</sup> channels to treat pain: T-type versus N-type
Gerald W. Zamponi, Christophe Altier
págs. 465-470
Pharmacological inhibitors of glycogen synthase kinase 3
Laurent Meijer, Marc Flajolet, Paul Greengard
págs. 471-480
Functional, molecular and pharmacological advances in 5-HT<sub>7</sub> receptor research
J. Gregor Sutcliffe, Peter B. Hedlund
págs. 481-486
Molecular properties of ATP-gated P2X receptor ion channels
Jonathan A. Roberts, Catherine Vial, Richard J. Evans
págs. 487-493
Techniques: Bioprospecting historical herbal texts by hunting for new leads in old tomes
Brent A. Bauer, Eric J. Buenz, John M. Riddle, Peter L. Elkin, David J. Schnepple, Timothy J. Motley
págs. 494-498
Techniques: Use of concatenated subunits for the study of ligand-gated ion channels
Frédéric Minier, Erwin Sigel
págs. 499-503
© 2001-2024 Fundación Dialnet · Todos los derechos reservados